These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 29147840

  • 1. Medulloblastoma in adults : A retrospective single institution analysis.
    Hadi I, Roengvoraphoj O, Niyazi M, Roeder F, Schüller U, Belka C, Nachbichler SB.
    Strahlenther Onkol; 2018 Mar; 194(3):225-234. PubMed ID: 29147840
    [Abstract] [Full Text] [Related]

  • 2. Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
    Atalar B, Ozsahin M, Call J, Napieralska A, Kamer S, Villa S, Erpolat P, Negretti L, Lassen-Ramshad Y, Onal C, Akyurek S, Ugurluer G, Baumert BG, Servagi-Vernat S, Miller RC, Ozyar E, Sio TT.
    Radiother Oncol; 2018 Apr; 127(1):96-102. PubMed ID: 29373196
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Local control in non-metastatic medulloblastoma.
    Christopherson KM, Bradley JA, Rotondo RL, Pincus DW, Fort JA, Morris CG, Mendenhall NP, Marcus RB, Indelicato DJ.
    Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
    [Abstract] [Full Text] [Related]

  • 5. Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.
    Rieken S, Gaiser T, Mohr A, Welzel T, Witt O, Kulozik AE, Wick W, Debus J, Combs SE.
    BMC Cancer; 2010 Aug 23; 10():450. PubMed ID: 20731859
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: A contemporary single-institution experience.
    Saraf A, Yock TI, Niemierko A, Oh KS, Curry WT, Butler WE, Forst DA, Arrillaga-Romany I, Ebb DH, Tarbell NJ, MacDonald S, Loeffler JS, Shih HA.
    Neuro Oncol; 2022 Dec 01; 24(12):2180-2189. PubMed ID: 35671386
    [Abstract] [Full Text] [Related]

  • 7. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.
    Friedrich C, von Bueren AO, von Hoff K, Kwiecien R, Pietsch T, Warmuth-Metz M, Hau P, Deinlein F, Kuehl J, Kortmann RD, Rutkowski S.
    Eur J Cancer; 2013 Mar 01; 49(4):893-903. PubMed ID: 23182688
    [Abstract] [Full Text] [Related]

  • 8. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
    Khalil EM.
    J Egypt Natl Canc Inst; 2008 Jun 01; 20(2):175-86. PubMed ID: 20029474
    [Abstract] [Full Text] [Related]

  • 9. Metastatic medulloblastoma in adults: outcome of patients treated according to the HIT2000 protocol.
    von Bueren AO, Friedrich C, von Hoff K, Kwiecien R, Müller K, Pietsch T, Warmuth-Metz M, Hau P, Benesch M, Kuehl J, Kortmann RD, Rutkowski S.
    Eur J Cancer; 2015 Nov 01; 51(16):2434-43. PubMed ID: 26254812
    [Abstract] [Full Text] [Related]

  • 10. Outcome and prognostic factors of radiation therapy for medulloblastoma.
    Rieken S, Mohr A, Habermehl D, Welzel T, Lindel K, Witt O, Kulozik AE, Wick W, Debus J, Combs SE.
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):e7-e13. PubMed ID: 21345611
    [Abstract] [Full Text] [Related]

  • 11. Multicenter experience of adult medulloblastoma: A study of Anatolian Society of Medical Oncology (ASMO).
    Esbah O, Demirci U, Dane F, Gunaydsin Y, Ozdemir N, Siyar Ekinci A, Kodaz H, Yazilitas D, Rzayev R, Guney Y, Seker M, Uysal M, Inal A, Bilici A, Benekli M, Oksuzoglu B, Buyukberber S.
    J BUON; 2016 Nov 01; 21(2):456-60. PubMed ID: 27273958
    [Abstract] [Full Text] [Related]

  • 12. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
    Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF, Dauser R, Sanford RA, Fuller C, Lau C, Boyett JM, Wallace D, Gilbertson RJ.
    Lancet Oncol; 2006 Oct 01; 7(10):813-20. PubMed ID: 17012043
    [Abstract] [Full Text] [Related]

  • 13. Survival and prognostic factors in a series of adults with medulloblastomas.
    Riffaud L, Saikali S, Leray E, Hamlat A, Haegelen C, Vauleon E, Lesimple T.
    J Neurosurg; 2009 Sep 01; 111(3):478-87. PubMed ID: 19231932
    [Abstract] [Full Text] [Related]

  • 14. Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
    Beier D, Proescholdt M, Reinert C, Pietsch T, Jones DTW, Pfister SM, Hattingen E, Seidel C, Dirven L, Luerding R, Reijneveld J, Warmuth-Metz M, Bonsanto M, Bremer M, Combs SE, Rieken S, Herrlinger U, Kuntze H, Mayer-Steinacker R, Moskopp D, Schneider T, Beringer A, Schlegel U, Stummer W, Welker H, Weyerbrock A, Paulsen F, Rutkowski S, Weller M, Wick W, Kortmann RD, Bogdahn U, Hau P.
    Neuro Oncol; 2018 Feb 19; 20(3):400-410. PubMed ID: 29016837
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
    Zhang ZY, Xu J, Ren Y, Li KK, Ng HK, Mao Y, Zhong P, Yao Y, Zhou LF.
    PLoS One; 2014 Feb 19; 9(6):e99490. PubMed ID: 24932704
    [Abstract] [Full Text] [Related]

  • 17. Medulloblastoma--prognostic factors and outcome of treatment: review of the Mayo Clinic experience.
    Garton GR, Schomberg PJ, Scheithauer BW, Shaw EG, Ilstrup DM, Blackwell CR, Laws ER, Earle JD.
    Mayo Clin Proc; 1990 Aug 19; 65(8):1077-86. PubMed ID: 2117687
    [Abstract] [Full Text] [Related]

  • 18. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.
    Herrlinger U, Steinbrecher A, Rieger J, Hau P, Kortmann RD, Meyermann R, Schabet M, Bamberg M, Dichgans J, Bogdahn U, Weller M.
    J Neurol; 2005 Mar 19; 252(3):291-9. PubMed ID: 16189725
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prognostic role of chemotherapy, radiotherapy dose, and extent of surgical resection in adult medulloblastoma.
    Haque W, Verma V, Brian Butler E, Teh BS.
    J Clin Neurosci; 2020 Jun 19; 76():154-160. PubMed ID: 32291240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.